Difference between revisions of "Rituximab-rixa (Rixathon)"
Jump to navigation
Jump to search
(Created page with "'''Note: this is a rituximab biosimilar.''' ==Also known as== *'''Brand name:''' Rixathon Category:Drugs Category:Intravenous medications Category:Neutral Cat...") |
m |
||
| Line 1: | Line 1: | ||
| − | '''Note: this is a rituximab biosimilar.''' | + | '''Note: this is a rituximab biosimilar. It was not granted FDA approval but is approved in Europe.''' |
==Also known as== | ==Also known as== | ||
| + | *'''Code name:''' GP-2013 | ||
*'''Brand name:''' Rixathon | *'''Brand name:''' Rixathon | ||
| Line 10: | Line 11: | ||
[[Category:Anti-CD20 antibodies]] | [[Category:Anti-CD20 antibodies]] | ||
[[Category:Biosimilars]] | [[Category:Biosimilars]] | ||
| + | |||
| + | [[Category:EMA approved in 2017]] | ||
[[Category:Stub]] | [[Category:Stub]] | ||
Latest revision as of 12:48, 26 May 2024
Note: this is a rituximab biosimilar. It was not granted FDA approval but is approved in Europe.
Also known as
- Code name: GP-2013
- Brand name: Rixathon